Liver stiffness and severe fibrosis, as measured by FibroScan, are independently linked to type 2 diabetes (T2DM) in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), new ...

BOSTON — In the staging of liver fibrosis in the post-liver transplant setting, readings from noninvasive tests commonly have major discrepancies when compared with liver biopsy results, particularly ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Agile 3+ correctly identified more patients at high risk ...

Agile 3+ scores demonstrate superior discrimination for cardiovascular disease compared with Agile 4 and FAST scores in adults with MASLD.

BALTIMORE (KFSN) -- Thirty million Americans, or one in 10, have some form of liver disease. It could be scarring from a hepatitis C infection, cirrhosis or even liver cancer. Doctors are now using a ...

PARIS & WALTHAM, Mass.--(BUSINESS WIRE)--Echosens, a high-technology company offering the FibroScan ® portfolio of solutions, is pleased to announce that the “American Association of Clinical ...

-- Over 40% of participants treated with EFX 50mg for 96 weeks, compared with 0% for placebo, showed regression of liver fibrosis by all of three orthogonal measures: (1) ≥1-stage fibrosis improvement ...

The National Institute for Health and Care Excellence (NICE) is producing guidance on using Fibroscan in the NHS in England. The diagnostics advisory committee has considered the evidence and the ...